https://flcube.com/?p=23230
Sino Biopharmaceutical Secures Rights to Shionogi's COVID-19 Therapy Ensitrelvir - Insight, China's...
Jan 26, 2025 - China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that its subsidiary Jiangsu Chia Tai Tianqing Pharmaceutical Co., Ltd (CTTQ) has entered into...
sinobiopharmaceuticalrightscovidtherapy